Therapeutic methods using anti-CD200 antibodies
US9862767B2 · kind B2 · utility
3Cited by
32References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2015 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Apr 6, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to anti-CD200 antibodies and to use of the antibodies in methods for treating autoimmune disorders and cancer. Also featured are biomarkers for use in selecting or prescribing a treatment modality for a patient with an autoimmune disorder and/or cancer. In addition, the disclosure features methods of treatment using an anti-CD200 antibody in combination with one or more additional therapeutic agents such as an anti-CD20 therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.